TY - JOUR
T1 - Real-time diagnosis of H. pylori infection during endoscopy: Accuracy of an innovative tool (EndoFaster)
AU - Costamagna, Guido
AU - Zullo, Angelo
AU - Bizzotto, Alessandra
AU - Spada, Cristiano
AU - Hassan, Cesare
AU - Riccioni, Maria Elena
AU - Marmo, Clelia
AU - Strangio, Giuseppe
AU - Di Rienzo, Teresa Antonella
AU - Cammarota, Giovanni
AU - Gasbarrini, Antonio
AU - Repici, Alessandro
PY - 2016
Y1 - 2016
N2 - Background: EndoFaster is novel device able to perform real-time ammonium measurement in gastric juice allowing H. pylori diagnosis during endoscopy. This large study aimed to validate the accuracy of EndoFaster for real-time H. pylori detection. Methods: Consecutive patients who underwent upper endoscopy in two centres were prospectively enrolled. During endoscopy, 4 ml of gastric juice were aspirated to perform automatic analysis by EndoFaster within 90 seconds, and H. pylori was considered present (>62 ppm/ml) or absent (≤62 ppm/ml). Accuracy was measured by using histology as gold standard, and 13C-urea breath test (UBT) in discordant cases. Accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) were calculated. Results: Overall, 189 patients were enrolled, but in seven (3.4%) the aspirated gastric juice amount was insufficient to perform the test. The accuracy, sensitivity, specificity, PPV, and NPV were 87.4%, 90.3%, 85.5%, 80.2%, 93.1%, respectively, and 92.6%, 97.1%, 89.7%, 85.9%, 98.0%, respectively, when H. pylori status was reclassified according to the UBT result in discordant cases. Conclusions: This study found a high accuracy/feasibility of EndoFaster for real-time H. pylori diagnosis. Use of EndoFaster may allow selecting those patients in whom routine gastric biopsies could be avoided.
AB - Background: EndoFaster is novel device able to perform real-time ammonium measurement in gastric juice allowing H. pylori diagnosis during endoscopy. This large study aimed to validate the accuracy of EndoFaster for real-time H. pylori detection. Methods: Consecutive patients who underwent upper endoscopy in two centres were prospectively enrolled. During endoscopy, 4 ml of gastric juice were aspirated to perform automatic analysis by EndoFaster within 90 seconds, and H. pylori was considered present (>62 ppm/ml) or absent (≤62 ppm/ml). Accuracy was measured by using histology as gold standard, and 13C-urea breath test (UBT) in discordant cases. Accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) were calculated. Results: Overall, 189 patients were enrolled, but in seven (3.4%) the aspirated gastric juice amount was insufficient to perform the test. The accuracy, sensitivity, specificity, PPV, and NPV were 87.4%, 90.3%, 85.5%, 80.2%, 93.1%, respectively, and 92.6%, 97.1%, 89.7%, 85.9%, 98.0%, respectively, when H. pylori status was reclassified according to the UBT result in discordant cases. Conclusions: This study found a high accuracy/feasibility of EndoFaster for real-time H. pylori diagnosis. Use of EndoFaster may allow selecting those patients in whom routine gastric biopsies could be avoided.
KW - EndoFaster
KW - Gastroenterology
KW - Helicobacter pylori
KW - Oncology
KW - diagnosis
KW - gastric juice
KW - histology
KW - urea breath test
KW - EndoFaster
KW - Gastroenterology
KW - Helicobacter pylori
KW - Oncology
KW - diagnosis
KW - gastric juice
KW - histology
KW - urea breath test
UR - http://hdl.handle.net/10807/93146
UR - http://ueg.sagepub.com/
U2 - 10.1177/2050640615610021
DO - 10.1177/2050640615610021
M3 - Article
SN - 2050-6406
VL - 4
SP - 339
EP - 342
JO - United European Gastroenterology Journal
JF - United European Gastroenterology Journal
ER -